Professional Documents
Culture Documents
Chikungunyafinalgroupa 180402165413
Chikungunyafinalgroupa 180402165413
Shakil Ahmed
BDS (DU), MPH (NSU)
Aim of This Presentation
To Highlight:
oImmunocompromised patients.
oViral mutation.
Note: Chikungunya shares some clinical signs with dengue and can be misdiagnosed in areas where
dengue is common.
Treatment of Chikungunya
oThere is no specific antiviral drug treatment for chikungunya.
AUTHORS:
AFFILIATION:
* Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine
and Metabolic Disorders (BIRDEM), Shahbagh, Dhaka
PAPER REVIEW…
JOURNAL DETAILS:
• BMC Research Notes, BioMed Central ( Online)
• Published on : 15 August 2017
• (Rahim and Uddin BMC Res Notes (2017) 10:410 DOI 10.1186/s13104-017-
2723-5)
• https://bmcresnotes.biomedcentral.com/articles/10.1186/s13104-017-2723-5
• bmcresnotes@biomedcentral.com
METHODOLOGY:
• A clinical case series study was conducted on admitted patients at the Department of
Internal Medicine, BIRDEM General Hospital in June, 2017
• All patients (n=7, 4 males, 3 females) presenting with fever (recorded temperature ≥
100.4˚F ) and clinically confirmed to have chikungunya by :
a positive “Anti-chikungunya antibody (IgM) ICT” test OR
a positive “RT-PCR” test
• A “register” of cases was made and reported
• Varied clinical presentations and laboratory findings among this group of patients
were analysed
• Co-infection with dengue fever was also explored
RESULTS:
• A. CLINICAL:
CLINICAL FEATURES NUMBER OF PATIENTS
AFFECTED
Fever 07
Rash 02
Arthralgia/Arthritis 05
(hands,feet,wrists,knees)
Gastrointestinal (vomiting, 04
diarrhoea)
Lymphadenopathy 01
Positive “RT-PCR” 03
• Study sample size (n=7) may not be representative of the total burden of
chikungunya cases in Banmgladesh
• The study could have been conducted over a longer period of time,
coinciding with the chikungunya outbreak till September of that year.